Evidence map›Paper›PMID 31018863›Full record

ArticleJournal of medical case reports2019

Hurler-Scheie syndrome in Niger: a case series.

Hamid Assadeck, Moussa Toudou Daouda, Harouna Bako, Fatimata Hassane Djibo

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Mucopolysaccharidosis type I Hurler-Scheie syndrome: a case report.Annals of medicine and surgery (2012) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hamid AssadeckDepartment of Neurology, National Hospital of Niamey, PO Box 238, Niamey, Niger.
Moussa Toudou DaoudaDepartment of Neurology, National Hospital of Niamey, PO Box 238, Niamey, Niger. moussatoudou@gmail.com.
Harouna BakoDepartment of Medicine and Medical Specialties, Faculty of Medicine and Pharmacy, Abdou Moumouni University, Niamey, Niger.
Fatimata Hassane DjiboDepartment of Neurology, National Hospital of Niamey, PO Box 238, Niamey, Niger.
National Hospital Niamey · NE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHurler-Scheie syndrome is an intermediate form of mucopolysaccharidosis type I which is a rare lysosomal storage disorder caused by the deficiency or complete absence of enzyme alpha-L-iduronidase activity. We report the first documented cases of Hurler-Scheie syndrome observed in Niger in a Touareg family. CASE PRESENTATION: We studied the case of two 12-year-old twin Touareg boys and their 10-year-old Touareg sister whose parents are first-degree cousins, and there was no history of similar cases in their previous generations. The diagnosis of Hurler-Scheie syndrome was considered in these patients on the basis of clinical and radiological arguments, with the highlighting of a deficiency of enzyme alpha-L-iduronidase in serum and leukocytes. The twins had presented the first symptoms at the age of 24 months and the diagnosis of Hurler-Scheie syndrome was made at the age of 12 years. In their younger sister, the first symptoms were observed at the age of 3 years and the diagnosis was made at the age of 10 years. The three probands were born after a normal full-term pregnancy and a spontaneous vaginal delivery according to their parents. Their birth weight, height, and head circumference were within normal limits according to their parents. The three probands were brought in for consultation for stunted growth, joint stiffness with gait disorders, deformities of the thoracolumbar spine, recurrent otitis media, decreased hearing, increased abdominal volume, snoring during sleep, and facial dysmorphism.

conclusionsEven in countries with limited access to diagnostic means, a good knowledge of the clinical manifestations of the disease can help to guide the diagnosis of mucopolysaccharidosis type I.

Indexed as

ChildDisease ProgressionEarly DiagnosisEnzyme Replacement TherapyFemaleHematopoietic Stem Cell TransplantationHumansMaleMucopolysaccharidosis INigerPedigreeHurler–Scheie syndromeMucopolysaccharidosis type INiger

Identifiers

PMID31018863
PMCPMC6482501
OpenAlexW2942252464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.